- HOME
- Rinsho Shinkeigaku (Clinical Neurology)
- Vol.64 No.2
Vol.64 No.2 contents
Invited Review
Clinical features and pathogenesis of Glial fibrillary acidic protein (GFAP) antibodyassociated disorders
Akio Kimura, M.D., PhD.
CLINICA NEUROL, 64: 75−84, 2024
Review
Central nervous system disorders secondary to histiocytoses: neurodegeneration with potential for improvement
Akira Morimoto, M.D., Ph.D. 1）, Kenichi Sakamoto, M.D., Ph.D. 2）, Ko Kudo, M.D. 3） and Yoko Shioda, M.D., Ph.D. 4）
CLINICA NEUROL, 64: 85−92, 2024
Case Report
Embolic stroke due to ascending aortic thrombus in a patient with treatment-resistant ulcerative colitis
Kenichi Inoue, M.D. 1）, Toshiyasu Ogata, M.D. 1）, Takayasu Mishima, M.D. 1）, Hideki Ishibashi, M.D. 2）, Fumihito Hirai, M.D., Ph.D. 2） and Yoshio Tsuboi, M.D., Ph.D. 1）
CLINICA NEUROL, 64: 93−98, 2024
Case Report
A case of Alice in Wonderland syndrome after Epstein-Barr virus (EBV) encephalitis: a mimicry of focal epileptic seizure
Kyoko Hosokawa, M.D. 1）2）, Kazuki Oi, M.D., Ph.D. 1）3）, Takefumi Hitomi, M.D., Ph.D. 4）, Takahiro Mitsueda, M.D., Ph.D. 5）, Tomokazu Nakagawa, M.D., Ph.D. 6）7） and Akio Ikeda, M.D., Ph.D. 8）
CLINICA NEUROL, 64: 99−104, 2024
Case Report
A case of spinal cord infarction presenting with unilateral C5 palsy
Tatsuki Matsuda, M.D.1）, Takahiko Taniguchi, M.D.1）, Misaki Hanya, M.D.1）, Keisuke Kitani, M.D.1）, Hisashi Takahashi, M.D.1）＊ and Takashi Kasai, M.D., Ph.D.2）
CLINICA NEUROL, 64: 105−108, 2024
Case Report
Eculizumab led to beneficial clinical course in a patient with generalized myasthenia gravis who developed COVID 19-associated pneumonia
Yusuke Kuroda, M.D. 1）2）, Gennya Watanabe, M.D. 1）, Kazuki Satou, M.D. 2）, Hirohiko Ono, M.D., Ph.D. 2）, Kennichi Tsukita, M.D. 1） and Yasushi Suzuki, M.D., Ph.D. 1）
CLINICA NEUROL, 64: 109−112, 2024
Brief Clinical Note
Clinical features and effects of shunt surgery in patients with progressive supranuclear palsy and idiopathic normal pressure hydrocephalus
Naoki Yamahara, M.D., Nobuaki Yoshikura, M.D., Ph.D. and Takayoshi Shimohata, M.D., Ph.D.
CLINICA NEUROL, 64: 113−116, 2024
